Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Lung CancerPneumonitisRadiation-Induced Lung InjuryImmunotherapy-Induced PneumonitisNon-Small-Cell Lung Cancer (NSCLC)
Interventions
DEVICE

incentive spirometry

The study will have one intervention group of patients using incentive spirometry in addition to standard of care treatment, including chemo/radiation and immunotherapy maintenance. Patients will use the incentive spirometer 10 times (10 breaths) every hour they are awake. Patients will be asked to start using the incentive spirometer as soon as they are enrolled in the study. Patients will be asked to continue to use incentive spirometry daily, including the duration of chemoradiation and up to three months post-treatment.

Trial Locations (1)

08103

RECRUITING

MD Anderson Cancer Center at Cooper, Camden

All Listed Sponsors
collaborator

The Cooper Foundation

UNKNOWN

lead

The Cooper Health System

OTHER